Suicidality and depression;Suicidalnost i depresija

Medicus

Volumn 13, Issue 1, 2004, Pages 77-87

  Kozarić Kovačić, Dragica ^a   Jendričko, Tihana ^a  

^a Odjel za Psihijatriju   (Croatia)

Author keywords

Depression; Pharmacotherapy; Suicidality; Therapeutic approaches

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; PSYCHOTROPIC AGENT;

ALCOHOL ABUSE; ANAMNESIS; ANXIETY DISORDER; BIPOLAR DISORDER; CLINICAL PRACTICE; COMORBIDITY; DEPRESSION; DRUG ABUSE; DRUG EFFICACY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; FAMILY HISTORY; HOMICIDE; HUMAN; LETHALITY; MENTAL DISEASE; MOOD DISORDER; PATIENT COMPLIANCE; PSYCHOSIS; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SIDE EFFECT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SUICIDAL BEHAVIOR; SUICIDE;

EID: 14544292380     PISSN: 1330013X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. SCHMIDKE A. Perspective: suicide in Europe. Suicide Life Threat Behav 1997;27:127-36.
2. Oxford English Dictionary. Oxford: Barraclough & Shepard; 1994.
3. MARIS RW, BERMAN AL, SILVERMAN MM. Comprehensive Textbook of Suicidology. New York, London: The Guilford Press; 2000.
4. SADOCK BJ, SADOCK VA. Kaplan & Sadock's synopsis of psychiatry. Virginia: Lippincott, Williams & Wilkins; 2003.
5. CAMUS A. Mit o Sizifu. Zagreb: Matica hrvatska; 1996.
6. GRUBIŠIĆ-ILIĆ M, KOZARIĆ- KOVAĆIĆ D, GRUBIŠIĆ F, KOVAČIĆ Z. Epidemiological study of suicide in the Republic of Croatia - comparison of war and post-war periods and areas directly and indirectly affected by war. Eur Psychiatry 2002;17:259-64.
7. BERMAN LA. "Suicide," Microsoft(r) Encarta(r) Online Encyclopedia 2004. Dostupno na URL adresi: http://encarta.msn.com. Datum pristupa informaciji, 2004.
8. KOZARIĆ-KOVAČIĆ D, GRUBIŠIĆ- ILIĆ M, GRUBIŠIĆ F, KOVAČIĆ Z. Epidemiological indicators of suicides in the Republic of Croatia. Društvena Istraživanja 2002;1:155-70.
9. NEELMAN J, HALPERN D, LEON D, LEWIS G. Tolerance on suicide, religion and suicide raters; an ecological and individual study in 19 Western countries. Psychol Med 1997;27:1165-71.
10. SHARMA R, MARKAR HR. Mortality in affective disorder. J Affect Disord 1994;31:91-6.
11. HOPES LM, WILLIAMS A. Depression, self-defeating, and self-destructive behaviours as predictors of suicide ideation in males and families. Psychol Rep 1999;84:63-6.
12. BULIK CM, CARPENTER LL, KUPFER DJ, FRANK E. Features associated with suicide attempts in recurrent major depression. J Affect Disord 1990;18:29-37.
13. MULLER-OERLINGHAUSEN B, BERGHOFER A, AHRENS B. The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Can J Psychiatry 2003;48:433-9.
14. GUZE SB, ROBINS E. Suicide and primary affective disorder. Br J Psychiatry 1970;117:437-8.
15. HARRIS EC, BARRACLOUGH B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997;170:205-28.
16. ISOMETSA E, HENRIKSSON M, ARO H, HEIKKINEN M, KUOPPASALMI K, LONNQVIST J. Suicide in psychotic major depression. J Affect Disord 1994;31:187-91.
17. GOODWIN FK, JAMISON KR. Manie-Depressive Illness. New York: Oxford University Press; 1990.
18. GOODWIN G. Establishing Treatment With Maintenance in Mind. Bipolar Global Medical Conference. Rome, Italy; 20-21 Sept 2004, str. 5.
19. KUPFER DJ, FRANK E, GROCHOCINSKI VJ, CLUSS PA, HOUCK PR, STAPF DA. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry 2002;63:120-5.
20. OSBY U, BRANDT L, CORREIA N, EKBOM A, SPAREN P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001;58:844-50.
21. DRUSS BG, BRADFORD WD, ROSENHECK RA, RADFORD MJ, KRUMHOLZ HM. Quality of medical care and excess mortality in older patients with mental disorders, Arch Gen Psychiatry 2001;58:565-72.
22. GELLER B, LUBY J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997;36:1168-76.
23. CHEN YW, DILSAVER SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry 1996;39:896-9.
24. MITCHELL PB. The Challenges of Bipolar Depression Treatment. Bipolar Global Medical Conference. Rome, Italy; 20-21 Sept 2004.
25. American Psychiatric Association. Practice Guidelines for the Treatment of Psychiatric Disorders. Arlington: American Psychiatric Association; 2004.
26. CONWELL Y, DUBERSTEIN PR, COX C, HERRMANN JH, FORBES NT, CAINE ED. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry 1996;153:1001-8.
27. MÄKELÄ P. Alcohol consumption and suicide mortality by age among Finnish men, 1950-1991. Addiction 1996;91:101-12.
28. BEAUTRAIS AL, JOYCE PR, MULDER RT, FERGUSSON DM, DEAVOLL BJ, NIGHTINGALE SK. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatry 1996;153:1009-14.
29. LESTER D. Suicidal behavior in bipolar and unipolar affective disorders: a meta-analysis. J Affect Disord 1993;27:117-21.
30. ISOMETSA ET, HENRIKSSON MM, ARO HM, HEIKKINEN ME, KUOPPASALMI KI, LÖNNQUIST JK. Suicide in major depression. Am J Psychiatry 1994;151:530-6.
31. FRANK E. Treatment Adherence: Preventing Relapse and Optimising Solutions for Wellness. Bipolar Global Medical Conference. Rome, Italy; 20-21 Sept 2004, str. 3-6.
32. COLOM F, VIETA E, SANCHEZ-MORENO J i sur. Psychoeducation in bipolar patients with comorbid personality disorders. Bipolar Disord 2004;6:294-8.
33. BALDESSARINI RJ, JAMISON KR. Effects of medical interventions in suicidal behavior. Summary and conclusions. J Clin Psychiatry 1999;60(Suppl 2):117-22.
34. ERNST CL, GOLDBERG JF. Antisuicide properties of psychotropic drugs: a critical review. Harv Rev Psychiatry 2004;12:14-41.
35. FREEMANTLE N, HOUSE A, SONG F, MASON JM, SHELDON TA. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. BMJ 1994;309:249-53.
36. CARLSTEN A, WAERN M, EKEDAHL A, RANSTAM J. Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf 2001;10:525-30.
37. CARLSTEN A, WAERN M, HOLMGREN P, ALLEBECK P. The role of benzodiazepines in elderly suicides. Scand J Public Health 2003;31:224-8.
38. TAYLOR D, PATON C, KERWIN R. The South London and Maudsley NHS Trust 2003 Prescribing Guidelines. 7. izd. London & New York: Martin Dunitz, Taylor & Francis Group; 2003.
39. McINTYRE RS, O'DONOVAN C. The human cost of not achieving full remission in depression. Can J Psychiatry 2004;49(3 Suppl 1):10S-16S.
40. BAKISH D. New standard od depression treatment: remission and full recovery. J Clin Psychiatry 2001;62(Suppl 26):5-9.
41. HEALY D. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom 2003;72:71-9.
42. JONSSON A, HOLMGREN P, AHLNER J. Fatal intoxications in a Swedish forensic autopsy material during 1992-2002. Forensic Sci Int 2004;143:53-9.
43. CHEETA S, SCHIFANO F, OYEFESO A, WEBB L, GHODSE AH. Antidepressant- realted deaths and antidepressant prescriptions in England and Wales, 1998-2000. Br J Psychiatry 2004;184:41-7.
44. HEALY D. Antidepressant era. Cambridge, MA: Harvard University Press; 1998.
45. LAPIERRE YD. Suicidality with selective serotonin reuptake inhibitors: Valid claim? J Psychiatry Neurosci 2003;28:340-7.
46. HAM P. Suicide risk not increased with SSRI antidepressants. J Fam Pract 2003;52:587-8.
47. KHAN A, KHAN S, KOLTS R, BROWN WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003;160:790-2.
48. MELTZER HY, ALPHS L, GREEN AI i sur. Clozapin treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003;60:82-91.
49. BALIT CR, LYNCH CN, ISBISTER GK, Bupropion poisoning: a case series. Med J Aust 2003;178:61-3.
50. KHAN A, KHAN SR, LEVENTHAL RM, BROWN WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database, Int J Neuropsychopharmacol 2001;4:113-8.
51. SALETU-ZYHLARZ GM, ANDERER P, ARNOLD O, SALETU B. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients. Neuropsychobiology 2003;48:194-208.
52. JICK SS, DEAN AD, JICK H. Antidepressants and suicide. BMJ 1995;310:215-8.
53. KENNEDY SH, LAM RW. Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics. Bipolar Disord 2003;5(Suppl 2):36-47.
54. SILVERSTONE PH, SILVERSTONE T. A review of acute treatments for bipolar depression. Int Clin Psychopharmacol 2004;19:113-24.
55. SERNYAK M, DESAI, R, STOLAR M, ROSENHECK R. Impact of clozapin on completed suicide. Am J Psychiatry 2001;158:931-7.
56. MELTZER HY. Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options. Curr Psychiatry Rep 2002;4:279-83.
57. COPPEN A. Lithium in unipolar depression and the prevention of suicide. J Clin Psychiatry 2000;61(Suppl 9):52-6.